Hopstem maps course to bring stem cell stroke therapy to US China's Hopstem has been cleared to move straight to a phase 2 trial in the US for its stem cell-based therapy to aid recovery after a stroke.

China's #HopstemBiotech has been cleared to start #clinicaltrials of a #stemcell-based therapy for #ischaemicstroke in the US, following negotiations with the FDA.

pharmaphorum.com/news/hopstem...